# Effect of an Innovative BIO Formula Intake on Infant Growth and Tolerance From 0 to 6 Months

> **NCT03936257** · NA · COMPLETED · sponsor: **Institut Pasteur de Lille** · enrollment: 100 (actual)

## Conditions studied

- Child Development

## Interventions

- **OTHER:** Breastfeeding
- **OTHER:** Conventional BIO Infant formula
- **OTHER:** TrueGreen BIO infant formula

## Key facts

- **NCT ID:** NCT03936257
- **Lead sponsor:** Institut Pasteur de Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2020-07-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03936257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03936257, "Effect of an Innovative BIO Formula Intake on Infant Growth and Tolerance From 0 to 6 Months". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT03936257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*